We provide genetic and biochemical proof that STAT5A and STAT5B hyperactivation can initiate T-ALL through TCR pathway hijacking and suggest similar mechanisms for other T cell cancers. The gene discussed is STAT5B; the disease is acute lymphoblastic leukemia.